Shionogi News
Most Popular Shionogi Story
QuatRx gains $125M licensing pact
QuatRx has scored a $125 million licensing deal with Shionogi. The Japanese company will pay $25 million of that upfront for the worldwide marketing rights to ospemifene for the treatment of... Read more...
Latest Headlines
- March 2, 2010
- December 22, 2009
- July 10, 2009
- September 2, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
